$ Value
$0
Shares
131,578
Price
$0
Filed
Aug 11
Insider
Name
BARABE TIMOTHY C
Title
—
CIK
0001237409
Roles
Transaction Details
Transaction Date
2025-08-11
Code
C
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Upon the closing of Heartflow, Inc.'s ("Heartflow") initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis. | The option will vest in full on the earlier of Heartflow's annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date.
Filing Info
BARABE TIMOTHY C's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-11 | HTFL | M | $19K |
| 2026-03-11 | HTFL | M | $0 |
| 2026-02-17 | HTFL | M | $21K |
| 2026-02-17 | HTFL | M | $0 |
| 2026-01-02 | RNAC | A | $0 |
| 2026-01-02 | RNAC | A | $0 |
| 2025-12-04 | RNAC | ▲ | $206K ★ |
| 2025-08-11 | HTFL | C | — |
| 2025-08-11 | HTFL | C | $0 |
| 2025-08-07 | HTFL | A | $0 |
Other Insiders at HTFL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BARABE TIMOTHY C | — | — | 2026-03-11 |
| HealthCor Partners Management LP | — | — | 2026-03-24 |
| Lightcap Jeffrey C | — | — | 2026-03-24 |
|
Rogers Campbell
Chief Medical Officer
|
— | $4.8M | 2026-04-01 |
| Bain Capital Life Sciences Investors, LLC | — | $56.1M | 2026-02-04 |
| Cullivan Julie A | — | $447K | 2026-03-05 |
|
Farquhar John C.M.
Chief Executive Officer
|
— | $1.8M | 2026-04-10 |
|
Jones Marie L.
Chief Accounting Officer, VP
|
— | — | 2026-02-06 |
|
Verghese Vikram
Chief Financial Officer
|
— | — | 2026-02-06 |